(Q73041725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

4

Stanley C Jordan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Mieko Toyoda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Andy Pao

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Anna Petrosian

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

156-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Accessory molecule regulation of naive CD4 T cell activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

The role of CD40 ligand in costimulation and T-cell activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Co-stimulation in T cell responses.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

The role of dendritic cells in T cell activation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Half-life and clearance of pH 6.8 and pH 4.25 immunoglobulin G intravenous preparations in patients with primary disorders of humoral immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

To die or not to die: an overview of apoptosis and its role in disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Antigen receptor cross-linking by anti-immunoglobulin antibodies coupled to cell surface membrane induces rapid apoptosis of normal spleen B cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Immune inhibitory receptors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

MHC-I-induced apoptosis in human B-lymphoma cells is dependent on protein tyrosine and serine/threonine kinases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Lymphocyte programmed cell death is mediated via HLA class II DR.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Apoptosis and disease: regulation and clinical relevance of programmed cell death

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

The role of Fas in autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00011.X

7 January 2021

10.1034/J.1600-6143.2003.00011.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12603211%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference